Thank you TOP for timeline reminder, i get so caught up in the day to day action, sometimes best still to look at the bigger picture, at least for now anyways.
TL;DR: Based on CHM meeting minutes, MHRA performance reports, and public reports on MAA submissions/approvals, DCVax-L will be approved between 11/14/24 and 1/31/25. Here's why:
Then you posted:
Contrary to one frequently shared opinion, DCVax-L appears to be moving faster through the process than other drugs.
Then on Feb 4 you posted , asserting early March would be the tail of the normal timeline.
No offense taken, I'm simply sharing information. Mainly to push back against the constant stream of complaints that DCVax-L is somehow behind schedule/receiving different treatment than other applications. For the next ~4.5 weeks, our application is squarely within the "normal" timeframe established by MHRA's recent performance.
And next month you will move the normal timeline again.
Have you collected any info on applications submitted after NWBO that we can be on the lookout for?
As far as I can tell, we're still "at bat" so to speak. Would like to reference some applications submitted after ours to see if we are getting passed over.
I'd also be curious to submit an inquiry to MHRA regarding the other applications to see if the response is similar to how they responded for NWBO's.